PerkinElmer to sell lighting and sensor business to private equity
This article was originally published in Clinica
PerkinElmer is to focus its efforts on the healthcare industry by divesting its illumination and detection solutions (IDS) to New York-based private equity firm Veritas Capital Fund. The deal is designed to boost PerkinElmer’s top-line growth, reduce the complexity of its portfolio and reduce exposure to more cyclical markets, the company said.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals